2 Minute Medicine |
Seven developments in asthma research
Healio Recent studies on asthma have focused on partial asthma control therapy and the use of mepolizumab to reduce exacerbations and glucocorticoid dosing in patients with eosinophilic asthma. Presentations at the European Respiratory Society International … Mepolizumab reduces exacerbations in severe eosinophilic asthma [MENSA trial] |
View full post on asthma – Google News